LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
15.58 27.76 17 685 0.0248 -0.1006
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
15.58 27.76 985 685 1.4368 1.1630
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
15.58 27.76 813 685 1.1859 1.0751
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
15.58 27.76 1034 685 1.5082 1.1858
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
15.58 27.76 14 685 0.0204 -0.1375
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
15.58 27.76 1175 685 1.7139 1.2470
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
17.28 27.76 17 838 0.0203 -0.0949
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
17.28 27.76 1045 838 1.2460 1.0915
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
17.28 27.76 940 838 1.1208 1.0469
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
17.28 27.76 993 838 1.1840 1.0699
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
17.28 27.76 18 838 0.0215 -0.0843
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
17.28 27.76 1247 838 1.4868 1.1680
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
18.98 27.76 23 941 0.0244 -0.0363
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
18.98 27.76 1069 941 1.1359 1.0508
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
18.98 27.76 1095 941 1.1635 1.0605
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
18.98 27.76 1140 941 1.2113 1.0769
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
18.98 27.76 39 941 0.0414 0.0692
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
18.98 27.76 1359 941 1.4440 1.1499
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
20.68 27.76 25 1119 0.0223 -0.0194
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
20.68 27.76 1188 1119 1.0617 1.0226
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
20.68 27.76 1105 1119 0.9875 0.9953
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
20.68 27.76 1146 1119 1.0241 1.0090
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
20.68 27.76 56 1119 0.0500 0.1406
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
20.68 27.76 1338 1119 1.1957 1.0682
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
22.39 27.76 22 1305 0.0168 -0.0410
MN20160318_Q01
E20